Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Study protocol

The providing resources to enhance African American patients’ readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial

Authors: Patti L Ephraim, Neil R Powe, Hamid Rabb, Jessica Ameling, Priscilla Auguste, LaPricia Lewis-Boyer, Raquel C Greer, Deidra C Crews, Tanjala S Purnell, Bernard G Jaar, Nicole DePasquale, L Ebony Boulware

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Living related kidney transplantation (LRT) is underutilized, particularly among African Americans. The effectiveness of informational and financial interventions to enhance informed decision-making among African Americans with end stage renal disease (ESRD) and improve rates of LRT is unknown.

Methods/design

We report the protocol of the Providing Resources to Enhance African American Patients’ Readiness to Make Decisions about Kidney Disease (PREPARED) Study, a two-phase study utilizing qualitative and quantitative research methods to design and test the effectiveness of informational (focused on shared decision-making) and financial interventions to overcome barriers to pursuit of LRT among African American patients and their families. Study Phase I involved the evidence-based development of informational materials as well as a financial intervention to enhance African American patients’ and families’ proficiency in shared decision-making regarding LRT. In Study Phase 2, we are currently conducting a randomized controlled trial in which patients with new-onset ESRD receive 1) usual dialysis care by their nephrologists, 2) the informational intervention (educational video and handbook), or 3) the informational intervention in addition to the option of participating in a live kidney donor financial assistance program. The primary outcome of the randomized controlled trial will include patients’ self-reported rates of consideration of LRT (including family discussions of LRT, patient-physician discussions of LRT, and identification of a LRT donor).

Discussion

Results from the PREPARED study will provide needed evidence on ways to enhance the decision to pursue LRT among African American patients with ESRD.

Trial registration

ClinicalTrials.gov NCT01439516
Appendix
Available only for authorised users
Literature
1.
2.
Gaston RS, Ayres I, Dooley LG, Diethelm AG: Racial equity in renal transplantation. the disparate impact of HLA-based allocation. JAMA. 1993, 270 (11): 1352-1356. 10.1001/jama.1993.03510110092038.CrossRefPubMed
3.
Young CJ, Gaston RS: Renal transplantation in black Americans. N Engl J Med. 2000, 343 (21): 1545-1552. 10.1056/NEJM200011233432107.CrossRefPubMed
4.
Ayanian JZ, Cleary PD, Weissman JS, Epstein AM: The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med. 1999, 341 (22): 1661-1669. 10.1056/NEJM199911253412206.CrossRefPubMed
5.
Kasiske BL, London W, Ellison MD: Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol. 1998, 9 (11): 2142-2147.PubMed
6.
Soucie JM, Neylan JF, McClellan W: Race and sex differences in the identification of candidates for renal transplantation. Am J Kidney Dis. 1992, 19 (5): 414-419.CrossRefPubMed
7.
8.
Isaacs RB, Lobo PI, Nock SL, Hanson JA, Ojo AO, Pruett TL: Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States. Am J Kidney Dis. 2000, 36 (3): 526-533. 10.1053/ajkd.2000.9793.CrossRefPubMed
9.
Alexander GC, Sehgal AR: Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA. 1998, 280 (13): 1148-1152. 10.1001/jama.280.13.1148.CrossRefPubMed
10.
Alexander GC, Sehgal AR: Why hemodialysis patients fail to complete the transplantation process. Am J Kidney Dis. 2001, 37 (2): 321-328. 10.1053/ajkd.2001.21297.CrossRefPubMed
11.
Boulware LE, Meoni LA, Fink NE, et al: Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. Am J Transplant. 2005, 5 (6): 1503-1512. 10.1111/j.1600-6143.2005.00860.x.CrossRefPubMed
12.
Wolfe RA, Ashby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999, 341 (23): 1725-1730. 10.1056/NEJM199912023412303.CrossRefPubMed
13.
Ichikawa Y, Fujisawa M, Hirose E, et al: Quality of life in kidney transplant patients. Transplant Proc. 2000, 32 (7): 1815-1816. 10.1016/S0041-1345(00)01360-9.CrossRefPubMed
14.
Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F: Changes in quality of life after renal transplantation. Am J Kidney Dis. 1998, 32 (1): 93-100. 10.1053/ajkd.1998.v32.pm9669429.CrossRefPubMed
15.
Manninen DL, Evans RW, Dugan MK: Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. Clin Transpl. 1991, 193-203.
16.
Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M: Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives. Am J Transplant. 2004, 4 (4): 569-573. 10.1111/j.1600-6143.2004.00373.x.CrossRefPubMed
17.
Ojo A, Port FK: Influence of race and gender on related donor renal transplantation rates. Am J Kidney Dis. 1993, 22 (6): 835-841.CrossRefPubMed
18.
Purnell TS, Hall YN, Boulware LE: Understanding and overcoming barriers to living kidney donation among racial and ethnic minorities in the United States. Adv Chronic Kidney Dis. 2012, 19 (4): 244-251. 10.1053/j.ackd.2012.01.008.CrossRefPubMedPubMedCentral
19.
Boulware LE, Ephraim P, Hill-Briggs F, et al: Effectiveness of educational and behavioral interventions to improve pursuit of pre-emptive living-related kidney transplantation: The Talking About Living Kidney Donation (TALK) Study. Am J Transplant. 2011, 2: 28-211. 10.1111/j.1600-6143.2011.03533.x.
20.
Finkelstein FO, Story K, Firanek C, et al: Perceived knowledge among patients cared for by nephrologists about chronic kidney disease and end-stage renal disease therapies. Kidney Int. 2008, 74 (9): 1178-1184. 10.1038/ki.2008.376.CrossRefPubMed
21.
Shilling LM, Norman ML, Chavin KD, et al: Healthcare professionals' perceptions of the barriers to living donor kidney transplantation among African Americans. J Natl Med Assoc. 2006, 98 (6): 834-840.PubMedPubMedCentral
22.
Clarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX: The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant. 2006, 21 (7): 1952-1960. 10.1093/ndt/gfl069.CrossRefPubMed
23.
Boulware LE, Ratner LE, Sosa JA, et al: The general public's concerns about clinical risk in live kidney donation. Am J Transplant. 2002, 2 (2): 186-193. 10.1034/j.1600-6143.2002.020211.x.CrossRefPubMed
24.
Boulware LE, Troll MU, Wang NY, Powe NR: Public attitudes toward incentives for organ donation: a national study of different racial/ethnic and income groups. Am J Transplant. 2006, 6 (11): 2774-2785. 10.1111/j.1600-6143.2006.01532.x.CrossRefPubMed
25.
26.
Sheu J, Ephraim PE, Powe NR, et al: African American and non-African American patients’ and families’ experiences with decision making about renal replacement therapies. Qual Health Res. 2012, 22 (7): 997-1006. 10.1177/1049732312443427.CrossRefPubMedPubMedCentral
27.
Auguste P, Greer RC, Ephraim P, et al: Quality of evidence informing patients' choice of renal replacement modalty (RRM) [abstract]. Clin J Am Soc Nephrol. 2010, 21: 539A-(Proceedings of the American Society of Nephrology Renal Week 2010)
28.
Olufade T, Auguste P, Crews D, et al: Comparison of sexual dysfunction between renal replacement therapies: a systematic review [abstract]. J Am Soc Neph. 2011, 22: 204A-(Proceedings of the American Society of Nephrology Kidney Week)
29.
Crews D, Auguste P, Purnell TS, et al: Comparison of cognitive function across esrd treatment modalities: a systematic review [abstract]. J Am Soc Neph. 2011, 22: 256A-(Proceedings of the American Society of Nephrology Kidney Week)CrossRef
30.
Purnell T, Auguste P, Crews D, et al: Comparison of life participation outcomes between renal replacement therapy modalities: a systematic review [abstract]. J Am Soc Neph. 2011, 22: 734A-Proceedings of the American Society of Nephrology Kidney Week)
31.
Israni AK, Halpern SD, Zink S, Sidhwani SA, Caplan A: Incentive models to increase living kidney donation: encouraging without coercing. Am J Transplant. 2005, 5 (1): 15-20. 10.1111/j.1600-6143.2004.00656.x.CrossRefPubMed
32.
Goyal M, Mehta RL, Schneiderman LJ, Sehgal AR: Economic and health consequences of selling a kidney in India. JAMA. 2002, 288 (13): 1589-1593. 10.1001/jama.288.13.1589.CrossRefPubMed
33.
Matas AJ, Schnitzler M, Daar AS: Payment for living kidney donors (vendors) is not an abstract ethical discussion occurring in a vacuum. Am J Transplant. 2004, 4 (8): 1380-1381. 10.1111/j.1600-6143.2004.00487.x.CrossRefPubMed
34.
Organ Donation: Opportunities for Action. 2006, Washington, DC: The National Academies Press,
35.
Davis CL, Delmonico FL: Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol. 2005, 16 (7): 2098-2110. 10.1681/ASN.2004100824.CrossRefPubMed
36.
Jacobs C, Thomas C: Financial considerations in living organ donation. Prog Transplant. 2003, 13 (2): 130-136.CrossRefPubMed
37.
Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA: Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant. 2006, 6 (11): 2548-2555. 10.1111/j.1600-6143.2006.01492.x.CrossRefPubMed
38.
Wolters HH, Heidenreich S, Senninger N: Living donor kidney transplantation: chance for the recipient–financial risk for the donor?. Transplant Proc. 2003, 35 (6): 2091-2092. 10.1016/S0041-1345(03)00675-4.CrossRefPubMed
39.
Steinbrook R: Public solicitation of organ donors. N Engl J Med. 2005, 353 (5): 441-444. 10.1056/NEJMp058151.CrossRefPubMed
40.
Monaco AP: Rewards for organ donation: the time has come. Kidney Int. 2006, 69 (6): 955-957. 10.1038/sj.ki.5000281.CrossRefPubMed
41.
Elwyn G, O'Connor A, Stacey D, et al: Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006, 333 (7565): 417-10.1136/bmj.38926.629329.AE.CrossRefPubMedPubMedCentral
42.
Borson S, Scanlan J, Chen P, Ganguli M: The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003, 51 (10): 1451-1454. 10.1046/j.1532-5415.2003.51465.x.CrossRefPubMed
43.
44.
45.
46.
Good MJD, Smilkstein G, Good BJ, Shaffer T, Arons T: The family APGAR index: a study of construct validity. J Fam Pract. 1979, 8: 577-582.
47.
48.
Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of prime-md: the phq primary care study. primary care evaluation of mental disorders. patient health questionnaire. JAMA. 1999, 282 (18): 1737-1744. 10.1001/jama.282.18.1737.CrossRefPubMed
49.
Prawitz AD, Garman ET, Sorhaindo B, Kim J, O'Neill B, Drentea P: InCharge financial distress/financial well-being scale: development, norming, and score interpretation. Financ Couns Plan. 2006, 17 (1): 34-50.
50.
Davis TC, Long SW, Jackson RH, Mayeaux EJ, George RB, Crouch MA: Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993, 25 (6): 391-395.PubMed
51.
Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM: Measuring numeracy without a math test: Development of the Subjective Numeracy Scale (SNS). Med Decis Making. 2007, 27: 672-680. 10.1177/0272989X07304449.CrossRefPubMed
52.
Schapira MM, Davids SL, McAuliffe TL, Nattinger AB: Agreement between scales in the measurement of breast cancer risk perceptions. Risk Anal. 2004, 24 (3): 665-673. 10.1111/j.0272-4332.2004.00466.x.CrossRefPubMed
53.
LaVeist TA, Isaac LA, Williams KP: Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009, 44 (6): 2093-2105. 10.1111/j.1475-6773.2009.01017.x.CrossRefPubMedPubMedCentral
54.
Corbie-Smith G, Thomas SB, St Georg DM: Distrust, race, and research. Arch Intern Med. 2002, 162 (21): 2458-2463. 10.1001/archinte.162.21.2458.CrossRefPubMed
55.
Hemmelgarn BR, Manns BJ, Quan H, Ghali WA: Adapting the charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis. 2003, 42: 125-132. 10.1016/S0272-6386(03)00415-3.CrossRefPubMed
56.
57.
United Network for Organ Sharing: OPTN / SRTR 2010 Annual Data Report. 2011, Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation,
58.
Rovner DR, Wills CE, Bonham V, et al: Decision aids for benign prostatic hyperplasia: applicability across race and education. Med Decis Making. 2004, 24 (4): 359-366. 10.1177/0272989X04267010.CrossRefPubMed
Metadata
Title
The providing resources to enhance African American patients’ readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial
Authors
Patti L Ephraim
Neil R Powe
Hamid Rabb
Jessica Ameling
Priscilla Auguste
LaPricia Lewis-Boyer
Raquel C Greer
Deidra C Crews
Tanjala S Purnell
Bernard G Jaar
Nicole DePasquale
L Ebony Boulware
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-135

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue

Research article

Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study

Research article

The impact of an “acute dialysis start” on the mortality attributed to the use of central venous catheters: a retrospective cohort study

Research article

Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women

Research article

Kidney biopsy in patients with glomerulonephritis: is the earlier the better?

Research article

Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan

Research article

High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits